candesartan has been researched along with ascorbic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kuji, N; Masumori-Maemoto, S; Sugimoto, K; Ueda, S; Umemura, S; Wada, A | 1 |
1 review(s) available for candesartan and ascorbic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for candesartan and ascorbic acid
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Angiotensin II attenuates the vasodilating effect of a nitric oxide donor, glyceryl trinitrate: roles of superoxide and angiotensin II type 1 receptors.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensins; Antihypertensive Agents; Antioxidants; Ascorbic Acid; Benzimidazoles; Biphenyl Compounds; Humans; Infusions, Intra-Arterial; Male; Nitric Oxide Donors; Nitroglycerin; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reference Values; Research Design; Superoxides; Tetrazoles; Vasoconstriction; Vasodilator Agents | 2002 |